MIRATI THERAPEUTICS

mirati-therapeutics-logo

Mirati Therapeutics Inc is a Biotechnology company located in 9363 Towne Centre Dr, San Diego, CA, United States.

#SimilarOrganizations #People #Financial #Event #Website #More

MIRATI THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Medical

Founded:
1995-12-13

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.mirati.com

Total Employee:
251+

Status:
Active

Contact:
(858) 332-3410

Email Addresses:
info@mirati.com

Total Funding:
2.01 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics


Similar Organizations

apt-therapeutics-logo

APT Therapeutics

APT Therapeutics is a Biotechnology company located in 4041 Forest Park Ave., St. Louis, MO, United States.

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

lineage-cell-therapeutics-logo

Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

ngm-biopharmaceuticals-logo

NGM Biopharmaceuticals

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

viracta-therapeutics-logo

Viracta Therapeutics

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.


Current Advisors List

henry-j-fuchs_image

Henry J. Fuchs Board Member @ Mirati Therapeutics
Board_member
2012-02-01

julie-cherrington_image

Julie Cherrington Board Member @ Mirati Therapeutics
Board_member
2019-01-01

not_available_image

William Ringo Member of the Board of Directors @ Mirati Therapeutics
Board_member

Current Employees Featured

charles-m-baum_image

Charles M Baum
Charles M Baum Chief Executive Officer and President @ Mirati Therapeutics
Chief Executive Officer and President
2012-11-01

laurie-stelzer_image

Laurie Stelzer
Laurie Stelzer Executive Vice President & Chief Financial Officer @ Mirati Therapeutics
Executive Vice President & Chief Financial Officer
2022-05-01

david-meek_image

David Meek
David Meek CEO @ Mirati Therapeutics
CEO
2021-09-01

joseph-leveque_image

Joseph Leveque
Joseph Leveque Chief Medical Officer @ Mirati Therapeutics
Chief Medical Officer
2020-05-01

daniel-faga_image

Daniel Faga
Daniel Faga COO @ Mirati Therapeutics
COO
2020-01-01

vickie-reed_image

Vickie Reed
Vickie Reed Senior Vice President & Chief Accounting Officer @ Mirati Therapeutics
Senior Vice President & Chief Accounting Officer
2020-01-01

james-christensen_image

James Christensen
James Christensen Chief Scientific Officer @ Mirati Therapeutics
Chief Scientific Officer
2013-07-01

Founder


charles-m-baum_image

Charles M Baum

Stock Details


Company's stock symbol is NASDAQ:MRTX

Acquisitions List

Date Company Article Price
2013-06-28 MethylGene MethylGene acquired by Mirati Therapeutics N/A

Investments List

Date Company Article Money raised
2021-04-19 Stand Up To Cancer Mirati Therapeutics investment in Grant - Stand Up To Cancer 4 M USD

Official Site Inspections

http://www.mirati.com Semrush global rank: 1.12 M Semrush visits lastest month: 28.75 K

  • Host name: 45.60.150.161
  • IP address: 45.60.150.161
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Mirati Therapeutics"

Mirati Therapeutics - Crunchbase Company Profile & Funding

View contacts for Mirati Therapeutics to access new leads and connect with decision-makers. Mirati Therapeutics Inc is a Biotechnology company located in 9363 Towne Centre Dr, San …See details»

Mirati Therapeutics - Wikipedia

Mirati Therapeutics works largely in KRAS-mutation inhibition, and developing treatments for tumors that contain it. The inhibition to the mutation has shown to shrink the size of its tumors. The company is based in San Diego, California. The company’s name comes from the Italian word for “targeted” (Mirati). Mirati Therapeutics is traded on the Nasdaq under the ticker symbol MRTX. It joined the exchange in 2013. See details»

Mirati Therapeutics - The Org

Mirati Therapeutics Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones.See details»

Mira Murati, OpenAI’s technology chief, becomes the …

Sep 25, 2024 · OpenAI Chief Technology Officer Mira Murati — who has been instrumental in the development of ChatGPT and the artificial intelligence image generator Dall-E — said Wednesday she is leaving the...See details»

Mirati Therapeutics - Craft

Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. It provides Kirsten RAT sarcoma virus (KRAS) and …See details»

Mirati Therapeutics - Contacts, Employees, Board Members

Mirati Therapeutics has 6 current employee profiles, including Chief Executive Officer and President Charles M Baum. Mirati Therapeutics has 4 board members and advisors, including …See details»

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics ...

Jan 23, 2024 · With the completion of the acquisition, Mirati shares have ceased trading on the NASDAQ Global Select Market and Mirati is now a wholly owned subsidiary of Bristol Myers …See details»

Mirati Therapeutics, Inc. | Insights

Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Mirati announces CEO resignation, then a $250M public offering …

Aug 8, 2023 · David Meek, the CEO of Mirati Therapeutics, has resigned from the biotech and its board, the San Diego drug developer said Tuesday after the markets closed. Minutes later, …See details»

Bristol Myers Squibb Strengthens and Diversifies Oncology …

Oct 8, 2023 · Mirati is a commercial stage targeted oncology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with …See details»

Who Is Mira Murati, OpenAI’s Interim CEO? - The New York Times

Nov 17, 2023 · For years, Mira Murati has worked behind the scenes at OpenAI, overseeing the development and delivery of revolutionary products such as ChatGPT and DALL-E. Now, she …See details»

OpenAI CTO Mira Murati is leaving the ChatGPT maker | Fortune

Sep 25, 2024 · OpenAI chief technology officer Mira Murati announced her resignation on Wednesday, a surprise change at the top of the influential AI company as it seeks to raise …See details»

6 things to know about Mira Murati, OpenAI's CTO - Fast Company

Dec 1, 2023 · Murati is the chief technology officer at OpenAI, the startup behind ChatGPT—the most advanced AI chatbot ever to be deployed to a mass audience—and Fast Company ’s …See details»

Securities filing details BMS' yearslong courtship of Mirati

Oct 24, 2023 · Mirati Therapeutics was long rumored to be the target of a Big Pharma buyout before Bristol Myers Squibb put up $5.8 billion for the California-based cancer drug developer …See details»

MOCETINOSTAT - National Center for Advancing Translational …

Mocetinostat is an rationally designed, orally available, Class 1-selective, small molecule, 2-aminobenzamide HDAC inhibitor with potential antineoplastic activity.See details»

HOME | Mirati Consultancies

Mirati Consultancies provides: marketing research & corporate consultancy, general marketing, advertising consultancy, high standard strategic marketing and corporate restructuring, …See details»

The KRASG12C Inhibitor MRTX849 Reconditions the Tumor …

Jun 1, 2021 · KRAS G12C inhibitors, including MRTX849, are promising treatment options for KRAS-mutant non–small cell lung cancer (NSCLC). PD-1 inhibitors are approved in NSCLC; …See details»

Global Biopharmaceutical Company - Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.See details»

Miradi - Conservation Gateway

Miradi - a Swahili word meaning "project" or "goal" – was built as an open source tool to help conservation practitioners to design, manage, monitor, and learn from their projects to more …See details»

linkstock.net © 2022. All rights reserved